This study is not affiliated with PCOS Challenge, Inc.
The announcement below is being provided for informational purposes only.*

The Investigational REBALANCE Study for
PCOS-Related Infertility Is Now Enrolling
Women with Infertility Due to
Polycystic Ovary Syndrome
Participants will be compensated for
their time and travel to attend study visits.
See Below for Details and Eligibility Criteria
Study Title
Trial Site Locations
Clinical trial sites are currently available across the United States. More sites to be announced.
City, State
- San Francisco, CA – UCSF Center for Reproductive Health
- Winter Park, FL – The IVF Center
- Iowa City, IA – University of Iowa Hospitals and Clinics
- Wichita, KS – Cypress Medical Research Center
- Rochester, NY – University of Rochester, Strong Fertility Center
- Charlotte, NC – Reach Fertility
- Raleigh, NC – UNC Fertility
- Oklahoma City, OK – University of Oklahoma Health Sciences Center
- Saint Louis, MO – Washington University Fertility and Reproductive Medicine Center
- Hershey, PA – Penn State College of Medicine
- Philadelphia, PA – Penn Fertility Care
- San Antonio, TX – UT Health San Antonio
- Temple, TX – Baylor Scott & White Medical Center
- Middleton, WI – UW Health Generations Fertility Care
Estimated Time Commitment for Study Participants
- Initial Procedure: The investigational Ovarian Rebalancing procedure takes about one hour and is done in an outpatient setting under sedation.
- Weekly Blood Tests: For up to three months following the procedure, participants will undergo weekly blood tests to monitor ovulation.
- Follow-up Visits: There are scheduled follow-up visits at 3, 6, 9, 12, 24, and 36 months after the procedure.
- Follow-up Calls: There will also be follow-up calls at 24 hours, 7 days, and 30 days after the procedure.
Compensation
- Participants will be compensated for their time and travel to attend study visits.
How to Participate
- Complete the prescreening questionnaire.
- Potentially eligible participants will be contacted with additional details.
Principal Investigators
- Karl Hansen, MD, PhD, Oklahoma University Health Sciences Center
- Anuja Dokras, MD, PhD, Penn Fertility Care
For More Information About This Study
- Visit: https://rebalance-study.com/

CAUTION:
Investigational device.
Limited by United States law to investigational use.
Exclusively for clinical investigations.
*Disclaimer
- Category: PCOS Fertility, PCOS News, PCOS Research Studies
- No Comments